Health
ProAgio drug shows success against solid tumours in mice – Drug Target Review
Studies in mice have shown that the drug ProAgio is effective at treating pancreatic cancer and triple-negative breast cancer.
Posted: 10 February 2021 | Victoria Rees (Drug Target Review) | No comments yet
Studies in mice have shown that the drug ProAgio is effective at treating pancreatic cancer and triple-negative breast cancer.
A new drug named ProAgio has demonstrated efficacy at treating pancreatic cancer and prolonging survival in mice, according to a study. A second study also shows that the drug is effective against triple-negative breast cancer. The drug was developed by Georgia State University, US, Professor…
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News11 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred